Ligand cross-reactivity within the protease-activated receptor family.
about
Thrombin inhibits tumor cell growth in association with up-regulation of p21(waf/cip1) and caspases via a p53-independent, STAT-1-dependent pathwayFactor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via endothelial protein C receptor-dependent recruitment of PAR-1Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMPSpecificity of coagulation factor signalingMechanisms of action of proteinase-activated receptor agonists on human plateletsEvidence that PAR-1 and PAR-2 mediate prostanoid-dependent contraction in isolated guinea-pig gallbladderMultiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arteriolesInitiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2Development and evaluation of small peptidomimetic ligands to protease-activated receptor-2 (PAR2) through the use of lipid tetheringThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsDifferential signaling by protease-activated receptors: implications for therapeutic targeting.Protease activated receptors: theme and variations.A highly potent agonist to protease-activated receptor-2 reveals apical activation of the airway epithelium resulting in Ca2+-regulated ion conductanceThe coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis.Interactions of mast cell tryptase with thrombin receptors and PAR-2.Protease activated receptor 2 and the cardiovascular systemNoncanonical PAR3 activation by factor Xa identifies a novel pathway for Tie2 activation and stabilization of vascular integrity.Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.Essential role for proteinase-activated receptor-2 in arthritis.Evidence for proteinase-activated receptor-2 (PAR-2)-mediated mitogenesis in coronary artery smooth muscle cells.Protease-activated receptor-2 turnover stimulated independently of receptor activation in porcine coronary endothelial cells.Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activationHeterogeneous mechanisms of endothelium-dependent relaxation for thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary arteryEnhanced contractile response to thrombin in the pregnant rat myometriumEffect of protease-activated receptor (PAR)-1, -2 and -4-activating peptides, thrombin and trypsin in rat isolated airwaysEnzymatic activation of endothelial protease-activated receptors is dependent on artery diameter in human and porcine isolated coronary arteries.Therapeutic potential of protease-activated receptor-1 antagonists.Signaling mechanism of thrombin-induced gingival fibroblast-populated collagen gel contraction.Modulation of airway smooth muscle tone by protease activated receptor-1,-2,-3 and -4 in trachea isolated from influenza A virus-infected miceProtease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosisProtease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER StatusPH motifs in PAR1&2 endow breast cancer growth.Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transportLuminal trypsin may regulate enterocytes through proteinase-activated receptor 2.Transactivation of the PAR1-PAR2 heterodimer by thrombin elicits β-arrestin-mediated endosomal signaling.Cofactoring and dimerization of proteinase-activated receptorsThe coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm.Low-density lipoprotein receptor-related protein 6 is a novel coreceptor of protease-activated receptor-2 in the dynamics of cancer-associated β-catenin stabilization.Coagulation and non-coagulation effects of thrombin.
P2860
Q22253244-89AE3EF4-7A80-4856-B7A6-B1F26AB155E4Q24299143-71FF3CF2-268F-4008-8824-7892ECF292D2Q24685943-90EF6E66-80FD-4849-8702-A04B56FB9F98Q28188159-D6244B99-0CDE-4DAB-BAD5-6864CD833E4EQ28192472-E16898F6-EE80-4815-A583-5353DA98BA06Q28344849-B14CF260-09DC-4E82-AC12-6BF55A95F110Q28344873-DEA72FBC-F106-44DC-9E8E-AE9A29333282Q28348328-34DF2F43-D639-4EF8-9CC3-400EB7FAFA5DQ28539692-B22B4534-007D-484C-A7DB-83C9BD7AF32CQ30486707-4C4BEA1E-2134-45B3-9788-9388C161097BQ33580620-A0F6199A-74FA-4FF6-9A04-228923A0F9A4Q34225983-41E43053-2563-4716-805F-20B6DA85F9A2Q34353956-52E9DB1D-0B6A-4D70-A281-72E2DFE8FBA8Q34358154-29DEBCA9-9D3A-4ECB-B39B-7604E9E71E3EQ34415372-04DF18E4-AB5C-4AFE-A5E6-5259C3027E7CQ34489984-969A8A0D-0569-4642-9370-E86DE339A8D9Q34580126-F04CF321-487B-4D6C-AC88-C68B8D456266Q34619626-EEC5941B-D493-4215-90C9-CD1A9CAD88C9Q34828059-63A7D19B-8554-411C-BDA7-F7235BA8930AQ35028718-D3D4405E-5DF4-4E3A-BEC3-800A86E7DF93Q35028926-411960ED-5426-4D4B-9B3D-5E9E0E025078Q35041642-649AD86A-8D40-4E03-A257-A9AB82DA6856Q35042191-82CD0803-04F5-4370-93EF-A5F232F14D18Q35043001-1B7CADAE-7BF7-423B-81A1-AC603AD19EA4Q35043021-B87D80A2-6C75-4C8C-BE9D-01366110425EQ35044412-5AE1D673-56A8-4EB5-BFE2-C3763063FA62Q35056060-28BFBBE7-D8B0-4592-A3B4-F39177126CFAQ35098624-31EAD91F-74D6-4801-9E90-37A2D52346FCQ35107587-53596261-6C65-40A2-BA0F-C7D7151897EAQ35620514-EDF080AD-4C86-46B4-AC41-F5A90C7F312AQ35695573-506B72AE-1040-4F85-9752-EE3A007BFB66Q35921287-BC2FD243-FC47-4A89-A5A0-F90CFFA4D68CQ36357012-C57787E2-BF7C-4B09-9F9B-2EB8B5DA6BA8Q36509120-72A0A0B0-C493-410A-A45A-04F31F9C6072Q36565261-14195BE4-DE28-4FD5-897F-F22222B89BE2Q36779515-340B4DBB-FC16-4967-98BE-D2DDE78A7ECCQ37236116-F6DA1987-0846-47AD-9081-40F83F3C9A50Q37646912-92A69ABE-AC92-4299-A0E6-1789B9CAC42AQ38728933-E05C4DC7-5868-45B6-8C80-580E2B53A816Q38924721-C0EACF25-4439-46B7-9F2D-28B8975AB1AE
P2860
Ligand cross-reactivity within the protease-activated receptor family.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Ligand cross-reactivity within the protease-activated receptor family.
@en
Ligand cross-reactivity within the protease-activated receptor family.
@nl
type
label
Ligand cross-reactivity within the protease-activated receptor family.
@en
Ligand cross-reactivity within the protease-activated receptor family.
@nl
prefLabel
Ligand cross-reactivity within the protease-activated receptor family.
@en
Ligand cross-reactivity within the protease-activated receptor family.
@nl
P2093
P2860
P356
P1476
Ligand cross-reactivity within the protease-activated receptor family.
@en
P2093
Blackhart BD
Emilsson K
Martelli AJ
Scarborough RM
Sundelin J
P2860
P304
16466-16471
P356
10.1074/JBC.271.28.16466
P407
P577
1996-07-01T00:00:00Z